Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Akilimali NA"'
Autor:
Muema DM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Akilimali NA; Africa Health Research Institute, Durban, South Africa., Ndumnego OC; Africa Health Research Institute, Durban, South Africa., Rasehlo SS; Africa Health Research Institute, Durban, South Africa., Durgiah R; Africa Health Research Institute, Durban, South Africa., Ojwach DBA; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ismail N; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Dong M; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Moodley A; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Dong KL; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Ndhlovu ZM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Mabuka JM; Africa Health Research Institute, Durban, South Africa., Walker BD; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Mann JK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ndung'u T; Africa Health Research Institute, Durban, South Africa. thumbi.ndungu@ahri.org.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. thumbi.ndungu@ahri.org.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA. thumbi.ndungu@ahri.org.; Max Planck Institute for Infection Biology, Berlin, Germany. thumbi.ndungu@ahri.org.; Division of Infection and Immunity, University College London, London, UK. thumbi.ndungu@ahri.org.
Publikováno v:
BMC medicine [BMC Med] 2020 Mar 25; Vol. 18 (1), pp. 81. Date of Electronic Publication: 2020 Mar 25.
Autor:
Akilimali NA; Africa Health Research Institute (AHRI), Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa., Muema DM; Africa Health Research Institute (AHRI), Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Wellcome Trust Research Programme, Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya., Specht C; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA., Chang CC; Africa Health Research Institute (AHRI), Durban, South Africa.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia., Moosa MS; Africa Health Research Institute (AHRI), Durban, South Africa.; Department of Infectious Diseases, UKZN, Durban, South Africa., Levitz SM; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA., Lewin SR; The Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia., French MA; Medical School and School of Biomedical Sciences, University of Western Australia, Perth, Australia.; Department of Clinical Immunology, Royal Perth Hospital and PathWest Laboratory Medicine, Perth, Australia., Ndungʼu T; Africa Health Research Institute (AHRI), Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2019 Apr 15; Vol. 80 (5), pp. 596-604.
Autor:
Akilimali NA; Africa Health Research Institute.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa., Chang CC; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia., Muema DM; Africa Health Research Institute.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Kenya Medical Research Institute-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi., Reddy T; South African Medical Research Council, Overport., Moosa MS; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Department of Infectious Diseases, UKZN, King Edward VIII Hospital, Durban, South Africa., Lewin SR; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.; Peter Doherty Institute for Infection and Immunity, University of Melbourne, and Royal Melbourne Hospital., French MA; Medical School and School of Biomedical Sciences, University of Western Australia, Perth.; Department of Clinical Immunology, Royal Perth Hospital and PathWest Laboratory Medicine, Australia., Ndung'u T; Africa Health Research Institute.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN), Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2017 Oct 16; Vol. 65 (9), pp. 1551-1559.
Autor:
Bhattacharya D; Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India.; Medical Microbiology Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Danaviah S; Africa Health Research Institute, Durban, South Africa., Muema DM; Africa Health Research Institute, Durban, South Africa., Akilimali NA; Africa Health Research Institute, Durban, South Africa., Moodley P; Medical Microbiology Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Ndung'u T; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA, United States., Das G; Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India.
Publikováno v:
Frontiers in immunology [Front Immunol] 2017 Sep 11; Vol. 8, pp. 1120. Date of Electronic Publication: 2017 Sep 11 (Print Publication: 2017).
Autor:
Wong EB; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Akilimali NA; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa., Govender P; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa., Sullivan ZA; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America., Cosgrove C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom., Pillay M; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa., Lewinsohn DM; Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America ; Portland Veterans Administration Medical Center, Portland, Oregon, United States of America., Bishai WR; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America., Walker BD; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America., Ndung'u T; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America ; Max Planck Institute for Infection Biology, Berlin, Germany., Klenerman P; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom., Kasprowicz VO; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2013 Dec 31; Vol. 8 (12), pp. e83474. Date of Electronic Publication: 2013 Dec 31 (Print Publication: 2013).